Send to

Choose Destination
Curr Opin Investig Drugs. 2002 Jun;3(6):896-904.

Endothelium-targeted pharmacotherapeutics for the treatment of stroke.


The pathophysiology of stroke in humans is much more complex than what is typically studied in animal models. Embolic stroke models are more complex than pure ischemia models, but are more representative of human disease and may be particularly useful in the study of new therapeutic strategies. Vascular damage is a prominent feature of embolic stroke, and may be a useful therapeutic target. Serotonin antagonists, adenosine-regulating agents, free radical scavengers, matrix metalloproteinase inhibitors, and HMG-CoA reductase inhibitors are all potentially valuable agents in treating vascular damage after stroke. These agents facilitate decreased infarction volume, hemorrhage, and improved cerebral bloodflow.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center